4.1 Article

Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy

Related references

Note: Only part of the references are listed.
Article Dermatology

Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis

Andrea J. Gonzales et al.

VETERINARY DERMATOLOGY (2013)

Review Medicine, Research & Experimental

IL-6/IL-6 receptor system and its role in physiological and pathological conditions

Masahiko Mihara et al.

CLINICAL SCIENCE (2012)

Review Immunology

IL-12 family cytokines: immunological playmakers

Dario A. A. Vignali et al.

NATURE IMMUNOLOGY (2012)

Editorial Material Cell Biology

The JAK/STAT Pathway

Douglas A. Harrison

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Review Allergy

A Modular View of Cytokine Networks in Atopic Dermatitis

Irit Carmi-Levy et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)

Article Immunology

Lesional skin in atopic dogs shows a mixed Type-1 and Type-2 immune responsiveness

Yvette M. Schlotter et al.

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2011)

Article Biochemistry & Molecular Biology

Untangling the Complex Web of IL-4-and IL-13-Mediated Signaling Pathways

Marsha Wills-Karp et al.

SCIENCE SIGNALING (2008)

Review Cell Biology

Inteferons pen the JAK-STAT pathway

Christian Schindler et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)

Review Allergy

Immune dysregulation in atopic dermatitis

Peck Y. Ong et al.

CURRENT ALLERGY AND ASTHMA REPORTS (2006)